LeadIQ logo
Learn more at LeadIQ.com

Insights

Strategic Partnerships Dragonfly Therapeutics has formed strategic collaborations with industry giants like Merck, Gilead, and AbbVie. Leveraging these partnerships can open doors for cross-selling opportunities or co-marketing initiatives within the biotechnology sector.

High-profile Hires With high-profile hires like Dr. Joseph E. Eid, who led Merck's KEYTRUDA® development, Dragonfly Therapeutics demonstrates expertise in attracting top talent. Utilizing the expertise of such renowned professionals can enhance credibility and create selling opportunities for innovative therapies.

Diverse Pipeline Dragonfly's diverse pipeline, including wholly owned clinical assets and preclinical candidates, offers a range of innovative therapies under development. This variety can attract partnerships or licensing deals, presenting avenues for introducing new products to the market.

Expanding Research Collaborations Through expanding research collaborations with companies like AbbVie and Nonabio, Dragonfly establishes a network for knowledge sharing and joint development efforts. Utilizing these connections can lead to co-promotion opportunities or joint product launches for mutual sales growth.

Focus on Immune-mediated Diseases Dragonfly Therapeutics focuses on immune-mediated diseases, a niche area with high market demand. Positioning the company as a key player in this space can attract investor interest and potential licensing or acquisition deals for expanding product portfolios.

Similar companies to Dragonfly Therapeutics, Inc.

Dragonfly Therapeutics, Inc. Tech Stack

Dragonfly Therapeutics, Inc. uses 8 technology products and services including Wix, SAP, Oracle, and more. Explore Dragonfly Therapeutics, Inc.'s tech stack below.

  • Wix
    Content Management System
  • SAP
    Customer Relationship Management
  • Oracle
    Enterprise
  • Google Font API
    Font Scripts
  • Google Cloud
    Infrastructure As A Service
  • CTT
    Logistics
  • Microsoft
    Miscellaneous
  • New Relic
    Real User Monitoring

Media & News

Dragonfly Therapeutics, Inc.'s Email Address Formats

Dragonfly Therapeutics, Inc. uses at least 1 format(s):
Dragonfly Therapeutics, Inc. Email FormatsExamplePercentage
First.Last@dragonflytx.comJohn.Doe@dragonflytx.com
79%
First@dragonflytx.comJohn@dragonflytx.com
19%
FirstMiddle.Last@dragonflytx.comJohnMichael.Doe@dragonflytx.com
1%
First.Middle@dragonflytx.comJohn.Michael@dragonflytx.com
1%

Frequently Asked Questions

Where is Dragonfly Therapeutics, Inc.'s headquarters located?

Minus sign iconPlus sign icon
Dragonfly Therapeutics, Inc.'s main headquarters is located at Waltham, MA 02451 US. The company has employees across 3 continents, including North AmericaEuropeOceania.

What is Dragonfly Therapeutics, Inc.'s phone number?

Minus sign iconPlus sign icon
You can contact Dragonfly Therapeutics, Inc.'s main corporate office by phone at . For more prospecting data, LeadIQ has access to up-to-date and accurate contact information within our platform. Find, capture, and sync contact data to your CRM and sales tools in one click.

What is Dragonfly Therapeutics, Inc.'s official website and social media links?

Minus sign iconPlus sign icon
Dragonfly Therapeutics, Inc.'s official website is dragonflytx.com and has social profiles on LinkedIn.

How much revenue does Dragonfly Therapeutics, Inc. generate?

Minus sign iconPlus sign icon
As of September 2024, Dragonfly Therapeutics, Inc.'s annual revenue reached $35M.

What is Dragonfly Therapeutics, Inc.'s SIC code NAICS code?

Minus sign iconPlus sign icon
Dragonfly Therapeutics, Inc.'s SIC code is 8733 - Noncommercial Research Organizations NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does Dragonfly Therapeutics, Inc. have currently?

Minus sign iconPlus sign icon
As of September 2024, Dragonfly Therapeutics, Inc. has approximately 127 employees across 3 continents, including North AmericaEuropeOceania. Key team members include Chief Executive Officer: B. H.Chief Financial Officer: S. A.Chief Scientific Officer And Head Of Research And Development: A. C.. Explore Dragonfly Therapeutics, Inc.'s employee directory with LeadIQ.

What industry does Dragonfly Therapeutics, Inc. belong to?

Minus sign iconPlus sign icon
Dragonfly Therapeutics, Inc. operates in the Biotechnology Research industry.

What technology does Dragonfly Therapeutics, Inc. use?

Minus sign iconPlus sign icon
Dragonfly Therapeutics, Inc.'s tech stack includes WixSAPOracleGoogle Font APIGoogle CloudCTTMicrosoftNew Relic.

What is Dragonfly Therapeutics, Inc.'s email format?

Minus sign iconPlus sign icon
Dragonfly Therapeutics, Inc.'s email format typically follows the pattern of . Find more Dragonfly Therapeutics, Inc. email formats with LeadIQ.

When was Dragonfly Therapeutics, Inc. founded?

Minus sign iconPlus sign icon
Dragonfly Therapeutics, Inc. was founded in 2016.
Dragonfly Therapeutics, Inc.

Dragonfly Therapeutics, Inc.

Biotechnology ResearchMassachusetts, United States51-200 Employees

Dragonfly Therapeutics is a clinical-stage biopharmaceutical company committed to discovering, developing and commercializing therapies that use its novel multispecific antibody technology to harness the body's immune system to bring breakthrough treatments to patients. In addition to its wholly owned clinical assets, Dragonfly has a deep pipeline of wholly owned preclinical candidates discovered using its proprietary platform, as well as productive collaborations with Merck, AbbVie, Gilead and Bristol Myers Squibb in a broad range of disease areas. For more information, email info@dragonflytx.com.

Section iconCompany Overview

Headquarters
Waltham, MA 02451 US
Phone number
SIC Code
8733 - Noncommercial Research Organizations
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Founded
2016
Employees
51-200

Section iconMedia & News

Section iconFunding & Financials

  • $10M$50M

    Dragonfly Therapeutics, Inc.'s revenue is in the range of $10M$50M

Section iconFunding & Financials

  • $10M$50M

    Dragonfly Therapeutics, Inc.'s revenue is in the range of $10M$50M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.